Launching a Comparative Effectiveness Adaptive Platform Trial of Monoclonal Antibodies for COVID-19 in 21 Days.
Contemporary clinical trials（2022）
关键词
COVID-19,SARS-CoV-2,Monoclonal antibodies,Bamlanivimab,Etesevimab,Casirivimab,Imdevimab
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要